| Literature DB >> 12711083 |
Isabelle Jean1, Céline Lavialle, Annick Barthelaix-Pouplard, Catherine Fressinaud.
Abstract
In human central nervous system (CNS) demyelinating diseases, spontaneous remyelination is often incomplete. Therefore, we have tested whether neutrotrophin-3 (NT-3) accelerates CNS myelin repair after a chemically-induced demyelination. One group of adult rats was injected in the corpus callosum (CC) with 1 microl of 1% lysophosphatidylcholine (LPC) and 1 microl of NT-3 (1 microg/microl), and 15 days after injury (D15) remyelination was compared to control rats (receiving 1 microl of LPC+1 microl of vehicle buffer of NT-3). The demyelinated volume decreased by 56% in NT-3-treated rats at D15, and immunohistochemistry showed an increase in mature MBP(+) oligodendrocytes (OL) (+66%) in treated animals (whereas less mature (CNP(+)) OL were unchanged). Since less than 3% axons degenerate in this model, and as astrocytic gliosis was not modified, these data suggest that NT-3 acts directly on cells of the OL lineage to enhance remyelination in vivo.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12711083 DOI: 10.1016/s0006-8993(03)02510-1
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252